 Ding Xue
Concepts (348)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 42 | 2026 | 337 | 10.840 |
Why?
| | Caenorhabditis elegans Proteins | 38 | 2026 | 210 | 9.450 |
Why?
| | Apoptosis | 33 | 2022 | 2430 | 3.710 |
Why?
| | Caspases | 21 | 2017 | 232 | 3.480 |
Why?
| | Mitochondria | 12 | 2025 | 984 | 2.470 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 10 | 2019 | 240 | 1.970 |
Why?
| | Cathepsin B | 2 | 2026 | 16 | 1.580 |
Why?
| | Phosphatidylserines | 5 | 2013 | 60 | 1.320 |
Why?
| | Endodeoxyribonucleases | 7 | 2016 | 78 | 1.310 |
Why?
| | Mitochondrial Proteins | 7 | 2016 | 262 | 1.200 |
Why?
| | Embryonic Development | 4 | 2025 | 125 | 1.170 |
Why?
| | Phospholipid Transfer Proteins | 3 | 2019 | 7 | 1.130 |
Why?
| | Membrane Proteins | 9 | 2015 | 1166 | 1.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 4 | 2019 | 436 | 1.020 |
Why?
| | Repressor Proteins | 6 | 2016 | 437 | 0.950 |
Why?
| | Germ Cells | 5 | 2026 | 66 | 0.950 |
Why?
| | Mutagenesis | 2 | 2026 | 192 | 0.930 |
Why?
| | Carcinoma, Renal Cell | 4 | 2022 | 234 | 0.920 |
Why?
| | Animals | 54 | 2026 | 38058 | 0.890 |
Why?
| | DNA Fragmentation | 4 | 2016 | 39 | 0.870 |
Why?
| | Deoxyribonucleases | 4 | 2010 | 24 | 0.820 |
Why?
| | Kidney Neoplasms | 4 | 2022 | 412 | 0.810 |
Why?
| | Cell Division | 1 | 2025 | 766 | 0.780 |
Why?
| | Amino Acid Sequence | 17 | 2015 | 2155 | 0.770 |
Why?
| | Trans-Activators | 3 | 2019 | 405 | 0.750 |
Why?
| | Amino Acid Motifs | 4 | 2019 | 224 | 0.740 |
Why?
| | Intracellular Space | 2 | 2012 | 66 | 0.740 |
Why?
| | DNA, Helminth | 6 | 2010 | 26 | 0.730 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2023 | 190 | 0.710 |
Why?
| | Evolution, Molecular | 1 | 2026 | 514 | 0.710 |
Why?
| | Signal Transduction | 15 | 2026 | 5226 | 0.700 |
Why?
| | Embryo, Nonmammalian | 8 | 2025 | 173 | 0.700 |
Why?
| | DNA, Mitochondrial | 3 | 2023 | 211 | 0.690 |
Why?
| | Molecular Sequence Data | 16 | 2015 | 2930 | 0.660 |
Why?
| | Mutation | 16 | 2026 | 4089 | 0.640 |
Why?
| | Calcium-Binding Proteins | 3 | 2016 | 219 | 0.640 |
Why?
| | Animals, Genetically Modified | 8 | 2019 | 250 | 0.630 |
Why?
| | Sex Determination Processes | 2 | 2010 | 11 | 0.610 |
Why?
| | Apoptosis Regulatory Proteins | 5 | 2019 | 186 | 0.560 |
Why?
| | Carrier Proteins | 3 | 2021 | 737 | 0.550 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 377 | 0.550 |
Why?
| | Cadherins | 1 | 2019 | 201 | 0.540 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 82 | 0.530 |
Why?
| | Caspase Inhibitors | 4 | 2017 | 81 | 0.520 |
Why?
| | Calcium | 2 | 2012 | 1183 | 0.490 |
Why?
| | Fertilization | 1 | 2016 | 44 | 0.480 |
Why?
| | Cognition | 1 | 2024 | 1266 | 0.470 |
Why?
| | Intestines | 1 | 2019 | 358 | 0.460 |
Why?
| | RNA Interference | 7 | 2019 | 476 | 0.460 |
Why?
| | Nanoparticles | 4 | 2022 | 519 | 0.460 |
Why?
| | MicroRNAs | 2 | 2019 | 701 | 0.450 |
Why?
| | DNA | 4 | 2009 | 1463 | 0.440 |
Why?
| | Models, Molecular | 5 | 2021 | 1618 | 0.420 |
Why?
| | Molecular Biology | 1 | 2014 | 59 | 0.400 |
Why?
| | Optical Imaging | 4 | 2022 | 64 | 0.390 |
Why?
| | Caspase 3 | 1 | 2014 | 238 | 0.380 |
Why?
| | Microscopy, Immunoelectron | 1 | 2012 | 43 | 0.370 |
Why?
| | Protein Binding | 9 | 2021 | 2273 | 0.370 |
Why?
| | Phagocytosis | 4 | 2013 | 299 | 0.360 |
Why?
| | Germanium | 1 | 2012 | 2 | 0.360 |
Why?
| | Graphite | 1 | 2012 | 14 | 0.360 |
Why?
| | Autophagy | 3 | 2025 | 286 | 0.360 |
Why?
| | Fluorescent Dyes | 5 | 2021 | 329 | 0.350 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2012 | 118 | 0.350 |
Why?
| | Theranostic Nanomedicine | 3 | 2022 | 15 | 0.350 |
Why?
| | Proto-Oncogene Proteins | 3 | 2021 | 623 | 0.350 |
Why?
| | Hepatocytes | 1 | 2012 | 223 | 0.340 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 498 | 0.340 |
Why?
| | Lysosomes | 1 | 2011 | 128 | 0.340 |
Why?
| | Cell Membrane | 3 | 2013 | 706 | 0.330 |
Why?
| | Virus Replication | 2 | 2019 | 529 | 0.330 |
Why?
| | Intracellular Membranes | 2 | 2015 | 76 | 0.330 |
Why?
| | Carbon | 1 | 2012 | 203 | 0.320 |
Why?
| | Ribonuclease III | 1 | 2010 | 44 | 0.310 |
Why?
| | DNA Damage | 3 | 2026 | 430 | 0.310 |
Why?
| | Caspase 2 | 1 | 2009 | 12 | 0.300 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2015 | 396 | 0.290 |
Why?
| | Cysteine Endopeptidases | 3 | 2004 | 73 | 0.290 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2008 | 15 | 0.280 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2016 | 905 | 0.270 |
Why?
| | Receptors, Notch | 1 | 2008 | 92 | 0.270 |
Why?
| | Multienzyme Complexes | 2 | 2006 | 67 | 0.260 |
Why?
| | Cell Line, Tumor | 9 | 2022 | 3540 | 0.260 |
Why?
| | Protein Transport | 3 | 2021 | 441 | 0.260 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 458 | 0.260 |
Why?
| | Cloning, Molecular | 4 | 2015 | 540 | 0.260 |
Why?
| | Base Sequence | 5 | 2015 | 2190 | 0.260 |
Why?
| | Toluene | 1 | 2006 | 12 | 0.250 |
Why?
| | Benzene | 1 | 2006 | 18 | 0.250 |
Why?
| | Cobalt | 1 | 2007 | 53 | 0.250 |
Why?
| | Genome | 3 | 2014 | 306 | 0.250 |
Why?
| | Green Fluorescent Proteins | 3 | 2015 | 405 | 0.250 |
Why?
| | Helminth Proteins | 3 | 2001 | 24 | 0.250 |
Why?
| | Cell Death | 3 | 2015 | 383 | 0.250 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2021 | 1455 | 0.250 |
Why?
| | bcl-X Protein | 2 | 2019 | 45 | 0.250 |
Why?
| | Chlorobenzenes | 1 | 2006 | 19 | 0.240 |
Why?
| | Biphenyl Compounds | 1 | 2006 | 68 | 0.240 |
Why?
| | RNA-Binding Proteins | 1 | 2010 | 462 | 0.240 |
Why?
| | Hepatitis B virus | 2 | 2019 | 33 | 0.240 |
Why?
| | SELEX Aptamer Technique | 1 | 2006 | 16 | 0.240 |
Why?
| | Receptor, Insulin | 1 | 2026 | 94 | 0.240 |
Why?
| | Naphthalenes | 1 | 2006 | 56 | 0.240 |
Why?
| | Population Density | 1 | 2026 | 101 | 0.230 |
Why?
| | Viral Regulatory and Accessory Proteins | 3 | 2019 | 27 | 0.230 |
Why?
| | Structure-Activity Relationship | 3 | 2021 | 570 | 0.220 |
Why?
| | Blastomeres | 1 | 2025 | 11 | 0.220 |
Why?
| | Cytosol | 3 | 2012 | 227 | 0.220 |
Why?
| | Aptamers, Nucleotide | 1 | 2006 | 85 | 0.220 |
Why?
| | Enzyme Activation | 4 | 2015 | 766 | 0.220 |
Why?
| | Centrosome | 1 | 2025 | 71 | 0.220 |
Why?
| | Cell Cycle Proteins | 1 | 2008 | 628 | 0.210 |
Why?
| | Sexual Behavior, Animal | 1 | 2024 | 57 | 0.210 |
Why?
| | Embryo Loss | 1 | 2023 | 4 | 0.200 |
Why?
| | Permeability | 2 | 2015 | 168 | 0.200 |
Why?
| | Homeodomain Proteins | 1 | 2007 | 523 | 0.200 |
Why?
| | Mitosis | 1 | 2025 | 200 | 0.200 |
Why?
| | Recombinant Fusion Proteins | 4 | 2010 | 675 | 0.200 |
Why?
| | Forkhead Transcription Factors | 1 | 2024 | 202 | 0.200 |
Why?
| | Nuclear Proteins | 1 | 2008 | 748 | 0.190 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 156 | 0.190 |
Why?
| | Reproduction | 1 | 2024 | 207 | 0.190 |
Why?
| | Models, Biological | 4 | 2019 | 1821 | 0.190 |
Why?
| | Phototherapy | 2 | 2022 | 48 | 0.190 |
Why?
| | TNF Receptor-Associated Factor 1 | 1 | 2022 | 8 | 0.190 |
Why?
| | Sequence Alignment | 3 | 2009 | 366 | 0.180 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 621 | 0.180 |
Why?
| | Methyltransferases | 1 | 2022 | 74 | 0.170 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2608 | 0.170 |
Why?
| | Callithrix | 1 | 2021 | 12 | 0.170 |
Why?
| | Nuclear Receptor Subfamily 2, Group C, Member 2 | 1 | 2021 | 1 | 0.170 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2019 | 148 | 0.170 |
Why?
| | Pro-Opiomelanocortin | 1 | 2021 | 20 | 0.170 |
Why?
| | In Situ Nick-End Labeling | 3 | 2010 | 121 | 0.170 |
Why?
| | Behavior, Animal | 1 | 2024 | 519 | 0.170 |
Why?
| | Binding Sites | 3 | 2021 | 1329 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2003 | 427 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 151 | 0.160 |
Why?
| | Polymers | 2 | 2022 | 499 | 0.160 |
Why?
| | Nanomedicine | 1 | 2021 | 46 | 0.160 |
Why?
| | Phagocytes | 2 | 2012 | 81 | 0.160 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 159 | 0.160 |
Why?
| | Adenosine | 1 | 2022 | 255 | 0.160 |
Why?
| | Annexin A5 | 2 | 2012 | 21 | 0.160 |
Why?
| | Cysteine Proteases | 1 | 2019 | 8 | 0.150 |
Why?
| | Male | 13 | 2025 | 72315 | 0.150 |
Why?
| | Bystander Effect | 1 | 2019 | 19 | 0.150 |
Why?
| | Indocyanine Green | 1 | 2019 | 42 | 0.150 |
Why?
| | Transcription Factors | 1 | 2007 | 1741 | 0.150 |
Why?
| | Cerebral Angiography | 1 | 2019 | 119 | 0.150 |
Why?
| | Cell Survival | 4 | 2017 | 1098 | 0.150 |
Why?
| | Lasers | 1 | 2020 | 132 | 0.150 |
Why?
| | Nomograms | 1 | 2019 | 59 | 0.150 |
Why?
| | DNA Primers | 2 | 2015 | 512 | 0.150 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2019 | 255 | 0.140 |
Why?
| | Cell Tracking | 1 | 2018 | 19 | 0.140 |
Why?
| | Neoplasm Grading | 1 | 2019 | 307 | 0.140 |
Why?
| | Ubiquitin | 2 | 2011 | 86 | 0.140 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2018 | 18 | 0.140 |
Why?
| | Endocytosis | 1 | 2019 | 168 | 0.140 |
Why?
| | Microscopy, Fluorescence | 1 | 2019 | 416 | 0.140 |
Why?
| | Receptors, Steroid | 1 | 2018 | 45 | 0.130 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1782 | 0.130 |
Why?
| | Seminoma | 1 | 2018 | 20 | 0.130 |
Why?
| | Hep G2 Cells | 2 | 2019 | 74 | 0.130 |
Why?
| | Testicular Neoplasms | 1 | 2018 | 113 | 0.120 |
Why?
| | Phenotype | 3 | 2019 | 3162 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2023 | 600 | 0.120 |
Why?
| | Female | 8 | 2025 | 78271 | 0.120 |
Why?
| | Mitochondrial Membranes | 1 | 2016 | 40 | 0.120 |
Why?
| | Humans | 21 | 2023 | 144759 | 0.120 |
Why?
| | Surface Properties | 2 | 2020 | 410 | 0.120 |
Why?
| | Oxidation-Reduction | 3 | 2016 | 1087 | 0.120 |
Why?
| | Protein Conformation | 1 | 2019 | 946 | 0.120 |
Why?
| | Dynamins | 1 | 2015 | 36 | 0.120 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2007 | 157 | 0.110 |
Why?
| | Particle Size | 2 | 2020 | 411 | 0.110 |
Why?
| | Spermatozoa | 1 | 2016 | 109 | 0.110 |
Why?
| | Mice, Inbred ICR | 3 | 2020 | 113 | 0.110 |
Why?
| | Molecular Structure | 2 | 2006 | 499 | 0.110 |
Why?
| | Cell Movement | 1 | 2019 | 965 | 0.110 |
Why?
| | Time-Lapse Imaging | 1 | 2015 | 22 | 0.110 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1253 | 0.110 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 41 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2015 | 151 | 0.110 |
Why?
| | Pharynx | 2 | 2008 | 59 | 0.110 |
Why?
| | Cell Nucleus | 3 | 2003 | 618 | 0.110 |
Why?
| | Fluorescence | 1 | 2015 | 161 | 0.110 |
Why?
| | Computational Biology | 1 | 2019 | 680 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 338 | 0.100 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 318 | 0.100 |
Why?
| | Mammals | 1 | 2015 | 293 | 0.100 |
Why?
| | Genes, Suppressor | 1 | 2012 | 4 | 0.100 |
Why?
| | Transcriptome | 1 | 2019 | 1045 | 0.100 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1137 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 851 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1313 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 380 | 0.090 |
Why?
| | Blotting, Western | 1 | 2015 | 1187 | 0.090 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 138 | 0.090 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 388 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1054 | 0.090 |
Why?
| | Necrosis | 1 | 2012 | 244 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 824 | 0.090 |
Why?
| | Electrodes | 1 | 2012 | 114 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 862 | 0.090 |
Why?
| | Mice | 6 | 2021 | 18339 | 0.080 |
Why?
| | Lipids | 2 | 2015 | 710 | 0.080 |
Why?
| | Down-Regulation | 3 | 2021 | 627 | 0.080 |
Why?
| | Time Factors | 3 | 2014 | 7173 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2012 | 139 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 7190 | 0.080 |
Why?
| | RNA, Helminth | 1 | 2010 | 18 | 0.080 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 209 | 0.080 |
Why?
| | 3' Untranslated Regions | 1 | 2010 | 152 | 0.080 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 56 | 0.080 |
Why?
| | Alleles | 1 | 2013 | 879 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2018 | 2496 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 635 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 459 | 0.080 |
Why?
| | Infrared Rays | 2 | 2020 | 27 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2016 | 1339 | 0.070 |
Why?
| | Genes, bcl-2 | 1 | 2009 | 22 | 0.070 |
Why?
| | Catalytic Domain | 1 | 2010 | 232 | 0.070 |
Why?
| | Neurons | 2 | 2008 | 1640 | 0.070 |
Why?
| | Ubiquitin-Protein Ligase Complexes | 1 | 2008 | 8 | 0.070 |
Why?
| | Cullin Proteins | 1 | 2008 | 13 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2009 | 415 | 0.070 |
Why?
| | Recombinant Proteins | 2 | 2003 | 1370 | 0.070 |
Why?
| | Dimerization | 1 | 2008 | 194 | 0.070 |
Why?
| | POU Domain Factors | 1 | 2007 | 6 | 0.070 |
Why?
| | Muscle Cells | 1 | 2008 | 42 | 0.070 |
Why?
| | Genes, Helminth | 1 | 2007 | 30 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2008 | 245 | 0.070 |
Why?
| | X Chromosome | 1 | 2007 | 67 | 0.070 |
Why?
| | Protein Subunits | 1 | 2008 | 226 | 0.070 |
Why?
| | Benzene Derivatives | 1 | 2006 | 10 | 0.060 |
Why?
| | Brain | 1 | 2019 | 2933 | 0.060 |
Why?
| | Cyclohexanes | 1 | 2006 | 23 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2020 | 2452 | 0.060 |
Why?
| | Electrochemistry | 1 | 2007 | 73 | 0.060 |
Why?
| | Nucleic Acid Hybridization | 1 | 2007 | 187 | 0.060 |
Why?
| | Peptides | 1 | 2012 | 995 | 0.060 |
Why?
| | Staining and Labeling | 1 | 2007 | 151 | 0.060 |
Why?
| | Benzoquinones | 1 | 2006 | 47 | 0.060 |
Why?
| | Larva | 2 | 2014 | 242 | 0.060 |
Why?
| | Mutation, Missense | 1 | 2008 | 340 | 0.060 |
Why?
| | Oils | 1 | 2006 | 22 | 0.060 |
Why?
| | Crystallography, X-Ray | 2 | 2019 | 492 | 0.060 |
Why?
| | Carcinogens | 1 | 2006 | 122 | 0.060 |
Why?
| | Growth and Development | 1 | 2006 | 9 | 0.060 |
Why?
| | Cell Count | 1 | 2006 | 320 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1627 | 0.060 |
Why?
| | Catalysis | 1 | 2007 | 322 | 0.060 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 143 | 0.060 |
Why?
| | Biological Transport | 1 | 2007 | 417 | 0.060 |
Why?
| | Protein Structure, Secondary | 1 | 2006 | 369 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1047 | 0.050 |
Why?
| | Membrane Potentials | 1 | 2004 | 280 | 0.050 |
Why?
| | rac GTP-Binding Proteins | 1 | 2003 | 34 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 676 | 0.050 |
Why?
| | Peptide Hydrolases | 1 | 2004 | 105 | 0.050 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2003 | 64 | 0.050 |
Why?
| | Apoptosis Inducing Factor | 1 | 2002 | 3 | 0.050 |
Why?
| | Flavoproteins | 1 | 2002 | 8 | 0.050 |
Why?
| | Swimming | 1 | 2023 | 50 | 0.050 |
Why?
| | Hydrolysis | 1 | 2003 | 199 | 0.050 |
Why?
| | Acoustics | 1 | 2023 | 48 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8265 | 0.050 |
Why?
| | Pyridines | 1 | 2007 | 605 | 0.050 |
Why?
| | Sex Factors | 1 | 2008 | 2112 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2007 | 790 | 0.040 |
Why?
| | Genetic Complementation Test | 1 | 2001 | 66 | 0.040 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 463 | 0.040 |
Why?
| | Disease Progression | 2 | 2021 | 2847 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1985 | 0.040 |
Why?
| | Pituitary ACTH Hypersecretion | 1 | 2021 | 12 | 0.040 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 12 | 0.040 |
Why?
| | Quantum Dots | 1 | 2021 | 39 | 0.040 |
Why?
| | Mixed Function Oxygenases | 1 | 2021 | 49 | 0.040 |
Why?
| | Molecular Conformation | 1 | 2021 | 148 | 0.040 |
Why?
| | Alcohol Oxidoreductases | 1 | 2021 | 62 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 286 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2022 | 237 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 147 | 0.040 |
Why?
| | Microscopy, Interference | 1 | 2000 | 8 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1499 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 510 | 0.040 |
Why?
| | Aged | 4 | 2023 | 25913 | 0.040 |
Why?
| | Semiconductors | 1 | 2020 | 38 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4282 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2021 | 341 | 0.040 |
Why?
| | Drug Discovery | 1 | 2021 | 155 | 0.040 |
Why?
| | Intracranial Thrombosis | 1 | 2019 | 19 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2000 | 304 | 0.040 |
Why?
| | Disorders of Sex Development | 1 | 2000 | 40 | 0.040 |
Why?
| | HeLa Cells | 1 | 2001 | 650 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4557 | 0.040 |
Why?
| | Neoplasms | 1 | 2015 | 2875 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 310 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 192 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2019 | 321 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2018 | 191 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 173 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 181 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 928 | 0.030 |
Why?
| | Caspases, Initiator | 1 | 2017 | 17 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2017 | 91 | 0.030 |
Why?
| | Naproxen | 1 | 2017 | 21 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 682 | 0.030 |
Why?
| | Ketorolac | 1 | 2017 | 30 | 0.030 |
Why?
| | Ibuprofen | 1 | 2017 | 84 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2022 | 881 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2016 | 73 | 0.030 |
Why?
| | Protein Structure, Quaternary | 1 | 2016 | 116 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 508 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2017 | 388 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 219 | 0.030 |
Why?
| | Polyethylene Glycols | 1 | 2021 | 654 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 111 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1490 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2003 | 4154 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.030 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2014 | 7 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 175 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2016 | 213 | 0.030 |
Why?
| | HCT116 Cells | 1 | 2015 | 78 | 0.030 |
Why?
| | Genetic Pleiotropy | 1 | 2014 | 32 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 851 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2089 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2021 | 1496 | 0.030 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 84 | 0.030 |
Why?
| | Fluorouracil | 1 | 2015 | 235 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1462 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2014 | 192 | 0.020 |
Why?
| | Middle Aged | 3 | 2021 | 35875 | 0.020 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 6 | 0.020 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 8 | 0.020 |
Why?
| | Cell Lineage | 1 | 2014 | 376 | 0.020 |
Why?
| | Ligands | 1 | 2015 | 673 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 150 | 0.020 |
Why?
| | Adult | 3 | 2021 | 40449 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2882 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5408 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5992 | 0.020 |
Why?
| | Rats | 1 | 2012 | 5597 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 17066 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 14105 | 0.010 |
Why?
|
|
Xue's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|